1. Carter J., Weiss S., Linos K., et. al. Superficial CD34-positive fibroblastic tumor: report of 18 cases of a distinctive low-grade mesenchymal neoplasm of intermediate (borderline) malignancy. Mod Pathol 2014;27:294-302.

2. Lin T, Yang C, Juan K, Weng Y, Chen Y. Superficial CD34-Positive Fibroblastic Tumor: A Case Report and Review of the Literature. Am J Dermatopathol 2020;42(1):68-71.

3. Lao I, Yu L, Wang J. Superficial CD34-positive fibroblastic tumour: a clinicopathological and immunohistochemical study of an additional series. Histopathology 2017;70(3):394-401.

4. Fletcher CD, Evans BJ, MacArtney JC, et al. Dermatofibrosarcoma protuberans: a clinicopathological and immunohistochemical study with a review of the literature. Histopathology. 1985;9:921–938.

5. Rutgers EJ, Kronn BB, Albus-Lutter CE, et al. Dermatofibrosarcoma protuberans: treatment and prognosis. Eur J Surg Oncol. 1992;18:241–248.

6. Mentzel T, Beham A, Calonje E, et al. Epithelioid hemangioendothelioma of skin and soft tissues: clinicopathologic and immunohistochemical study of 30 cases. Am J Surg Pathol. 1997;21:363–374.

7. Errani C, Zhang L, Sung YS, et al. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer. 2011;50:644–653.

8. Miettinen M, Farnburg-Smith JV, Virolainen M, et al. Epithelioid sarcoma: an immunohistochemical analysis of 112 classical and variant cases and a discussion of the differential diagnosis. Hum Pathol. 1999;30:934–942.

9. Hornick J., Fletcher C. Pseudomyogenic Hemangioendothelioma, Am J Surg Pathol. 2011;35(2):190-201.

Acknowledgements

Author Profiles

Jill Browning, MD

Duke University

Jill Browning, MD, is a pathologist at the C. W. Bill Young VA Medical Center in Bay Pines, FL. She received her medical degree from LSUHSC-Shreveport. After completing AP/CP residency at Duke University, she completed a surgical pathology fellowship followed by a dermatopathology fellowship at Duke University.

Rami Al-Rohil, MBBS

Duke University

Rami N. Al-Rohil, MBBS, is an associate professor of pathology and dermatology and the dermatopathology fellowship program director at Duke University in Durham, NC. His area of clinical and research interest includes molecular alterations in cutaneous neoplasms with emphasis on melanocytic tumors and soft tissue neoplasms.